Home - Products - Angiogenesis - PDE - 5,7-Diacetoxy-8-methoxyflavone

5,7-Diacetoxy-8-methoxyflavone

CAS No. 23246-80-2

5,7-Diacetoxy-8-methoxyflavone( ZINC77031696 )

Catalog No. M29268 CAS No. 23246-80-2

5,7-Diacetoxy-8-methoxyflavone is derived from the roots of Scutellaria baicalensis and inhibits cAMP phosphodiesterase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 408 Get Quote
10MG 601 Get Quote
25MG 945 Get Quote
50MG 1278 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    5,7-Diacetoxy-8-methoxyflavone
  • Note
    Research use only, not for human use.
  • Brief Description
    5,7-Diacetoxy-8-methoxyflavone is derived from the roots of Scutellaria baicalensis and inhibits cAMP phosphodiesterase.
  • Description
    5,7-Diacetoxy-8-methoxyflavone is derived from the roots of Scutellaria baicalensis and inhibits cAMP phosphodiesterase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ZINC77031696
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23246-80-2
  • Formula Weight
    368.34
  • Molecular Formula
    C20H16O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OC=1C=C(OC(=O)C)C=2C(=O)C=C(OC2C1OC)C=3C=CC=CC3)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CI-1044

    CI-1044 is a potent, selective and orally bioavailable PDE4 inhibitor with IC50 of 0.27 uM.

  • MBCQ

    MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5.MBCQ, a selective PDE5 inhibitor, significantly decreased the EC(50) values for GTN-induced relaxation in both tolerant and nontolerant tissues, but with the greatest relative shift occurring in tolerant veins.

  • Isomazole

    Isomazole is a novel orally available phosphodiesterase (PDE) inhibitor with calcium-sensitizing properties that inhibits PDE3 and PDE4.